A AB BS S T TR RA AC CT T O Ob b j je ec c t ti i v ve e: : To in ves ti ga te the pro tec ti ve ef fect of me la to nin on the re ti nas of rats with strep to zo to cin (STZ)-in du ced di a be tes mel li tus (DM). M Ma a t te e r ri i a al l a an nd d M Me et t h ho od ds s: : Thre e gro ups of seven ma le Wis tar rats we re en rol led in this study: (1) a di a be tic gro up, (2) a di a be tic gro up tre a ted with me la to nin, and (3) con trol gro up. Di a be tes was in du ced with a sing le do se of 60 mg/kg in tra pe ri to ne al (i.p). STZ. In addition me la to nin (10 mg/kg/day) was in jec ted i.p. to rats in the tre at ment gro up. All ani mals we re eut ha ni zed 30 days la ter. Oxi da ti ve da ma ge was exami ned by me a su ring re ti nal ma lon di al dehy de (MDA) le vels. R Re e s su ul lt ts s: : The me an MDA le vels in tissu e we ight of re ti nas we re 55.68 ± 6.04 per 100 mg in di a be tic rats in du ced with STZ, 36.13 ± 7.48 per 100 mg in di a be tic rats tre a ted with me la to nin, and 23.04 ± 4.03 per 100 mg tis su e in con trol gro up. Re ti nal MDA le vels we re fo und dif fe rent sig ni fi cantly in both di a be tic gro up and me lato nin-tre a ted di a be tic gro up compared to the con trol gro up (p< 0.001). The re was al so a dif feren ce bet we en the di a be tic and me la to nin-tre a ted di a be tic gro ups for re ti nal MDA le vels (p< 0.01). MDA le vels of di a be tic ani mals tre a ted with me la to nin we re not dif fe rent from con trol gro up (p> 0.05). C Co on nc c l lu u s si i o on n: : Our study re ve a led that the me la to nin im pro ved the re ti nal da mage in di a be tic ma le rats in du ced with STZ and me la to nin had a pro tec ti ve ef fect aga inst the oxida ti ve da ma ge of DM.
The Protective Effect of Melatonin on the Retinas of Rats with StreptozotocinInduced Diabetes Mellitus A AB BS S T TR RA AC CT T O Ob b j je ec c t ti i v ve e: : To in ves ti ga te the pro tec ti ve ef fect of me la to nin on the re ti nas of rats with strep to zo to cin (STZ)-in du ced di a be tes mel li tus (DM). M Ma a t te e r ri i a al l a an nd d M Me et t h ho od ds s: : Thre e gro ups of seven ma le Wis tar rats we re en rol led in this study: (1) a di a be tic gro up, (2) a di a be tic gro up tre a ted with me la to nin, and (3) con trol gro up. Di a be tes was in du ced with a sing le do se of 60 mg/kg in tra pe ri to ne al (i.p). STZ. In addition me la to nin (10 mg/kg/day) was in jec ted i.p. to rats in the tre at ment gro up. All ani mals we re eut ha ni zed 30 days la ter. Oxi da ti ve da ma ge was exami ned by me a su ring re ti nal ma lon di al dehy de (MDA) le vels. R Re e s su ul lt ts s: : The me an MDA le vels in tissu e we ight of re ti nas we re 55.68 ± 6.04 per 100 mg in di a be tic rats in du ced with STZ, 36.13 ± 7.48 per 100 mg in di a be tic rats tre a ted with me la to nin, and 23.04 ± 4.03 per 100 mg tis su e in con trol gro up. Re ti nal MDA le vels we re fo und dif fe rent sig ni fi cantly in both di a be tic gro up and me lato nin-tre a ted di a be tic gro up compared to the con trol gro up (p< 0.001). The re was al so a dif feren ce bet we en the di a be tic and me la to nin-tre a ted di a be tic gro ups for re ti nal MDA le vels (p< 0.01). MDA le vels of di a be tic ani mals tre a ted with me la to nin we re not dif fe rent from con trol gro up (p> 0.05). C Co on nc c l lu u s si i o on n: : Our study re ve a led that the me la to nin im pro ved the re ti nal da mage in di a be tic ma le rats in du ced with STZ and me la to nin had a pro tec ti ve ef fect aga inst the oxida ti ve da ma ge of DM.
K Ke ey y W Wo or rd ds s: : Di a be tes mel li tus, ex pe ri men tal; me la to nin; mi toc hon dri al oxi da ti ve da ma ge en do nuc le a se; re ti na Ö ÖZ ZE ET T A Am ma aç ç: : Me la to ni nin strep to zo to sin (STZ) ile uya rıl mış Di a be tes Mel li tus' lu (DM) fa re le rin re ti na la rı üze rin de ki ko ru yu cu et ki si ni in ce le mek tir. G Ge e r re eç ç v ve e Y Yö ön n t te em m l le er r: : Bu ça lış ma ya di ya betik grup, me la to nin ve ri len di ya be tik grup ve kon trol gru bu ol mak üze re üç gru ba ayır mak su retiy le 21 Wis tar cin si fa re alın dı. Di ya be ti uyar mak için 60 mg/kg STZ tek doz pe ri ton içi ne uy gu lan dı. Ay rı ca te da vi gru bu na me la to nin 10 mg/kg/gün ola rak pe ri ton içi ne uy gu lan dı. Tüm fa re le re 30. gün öte na zi uy gu lan dı. Ok si da tif ha sar, re ti na da öl çü len ma lon di al de hid (MDA) sevi ye si ile be lir len di. B Bu ul l g gu u l la ar r: : Re ti na la rın her 100 mg ıslak ağır lık la rın da ki or ta la ma MDA se viye le ri sı ra sıy la, STZ ile uya rıl mış di ya bet li fa re ler de 55.68 ± 6.04 100 mg, me la to nin ve ri len di ya bet li fa re ler de 36.13 ± 7.48 ve kon trol gru bun da 23.04 ± 4.03 bu lun muş tur. Re ti na MDA sevi ye le ri di ya be tik fa re ler de ve me la to nin ve ri len di ya be tik fa re ler de kon trol gru bu na gö re an lamlı ola rak fark lı bu lun muş tur (p< 0.001). Di ya bet li ve me la to nin ve ri len di ya bet li fa re ler ara sın da da re ti na MDA se vi ye le ri ara sın da fark lı lık bu lun muş tur (p< 0.01). Me la to nin ile te da vi edi len diya be tik hay van la rın MDA se vi ye le ri ile kon trol gru bu ara sın da fark lı lık sap tan ma dı (p> 0.05). S So o n nu uç ç: : Ça lış ma mı zın so nuç la rı, me la to ni nin STZ ile uya rıl mış di ya be tik er kek fa re ler de re ti nal ha sa rı dü zelt ti ği ve di ya be tes mel li tu sa bağ lı ok si da tif ha sa ra kar şı ko ru yu cu et ki si ol du ğu nu gös -ter mek te dir.
A An na ah h t ta ar r K Ke e l li i m me e l le er r: : Di a be tes mel li tus, de ney sel; me la to nin; mi to kon dri ok si da tif ha sar en do nük le a zı; re ti na Ülkü ÇELİKER, MD i a be tes mel li tus (DM) is a com mon di sorder of glu co se me ta bo lism that has po tenti al of da ma ge in each or gan of the body. The most se ri o us comp li ca ti ons of di a be tes are reti no pathy, nep hro pathy and ne u ro pathy. Di a be tic re ti no pathy is the most com mon re ti nal vas cu lar di se a se. The prog res si on of di a be tic re ti no pathy is re la ted to many fac tors. 1 Mem bra ne li pid pe ro xida ti on in the re ti na is an early pat ho lo gi cal fin ding of oxi da ti ve stress as so ci a ted with DM.
2 High produc ti on ra te of re ac ti ve mo le cu les and high concen tra ti on of un sa tu ra ted fatty acids in the re ti na ren der the se cells sen si ti ve to li pid pe ro xi da ti on. 3 Li pid pe ro xi da ti on is known to ca u se gra du al changes in mem bra ne struc tu re le a ding to the loss of mem bra ne func ti on and se ve ral pat ho lo gi es such as di a be tic re ti no pathy, ca ta racts and gla u co ma. 4 Ma lon di al dehy de (MDA) le vel is wi dely used as a mar ker of li pid pe ro xi da ti on du ring in cre a sed oxida ti ve stress. 5 MDA can be me a su red spec trof lu oromet ri cally to de ter mi ne the le vel of oxi da ti ve da ma ge in the re ti na. 6 Strep to zo to cin (STZ) is the ma jor pre fer red che mi cal for in duc ti on of di a be tes in ex pe ri men tal ani mals and it acts by des tro ying pan cre a tic be ta cells. 7 The cyto to xic ac ti on of STZ is me di a ted by re ac ti ve oxy gen spe ci es. 7 Many stu di es ha ve be en per for med to des cri be the de vas ta ting ef fect of dia be tes in the dif fe rent or gans and tis su es inc lu ding ocu lar tis su es. Se ve ral mo le cu les such as ami no gua ni di ne, me la to nin, caf fe ic acid, and ra mip ril ha ve be en in ves ti ga ted. 8 Me la to nin has the po ten ti al effect to dec re a se the oxi da ti ve stress on the cor ne a in STZ-in du ced di a be tic rats. 9 The aim of this study was to in ves ti ga te the pro tec ti ve ef fects of exo ge no us me la to nin on re tinal da ma ge in STZ-in du ced di a be tic rats.
MA TE RI AL AND MET HODS
This study was per for med in comp li an ce with the AR VO (The Association for Research in Vision and Ophthalmology) re so lu ti on for the use of ani mals in Oph thal mic and Vi si on Re se arch. The study was ap pro ved by the Et hi cal Com mit te e of Fi rat Univer sity Scho ol of Me di ci ne; the te nets of the 2nd Dec la ra ti on of Hel sin ki we re fol lo wed.
One eye of 21 ma le Wis tar rats at 4 to 5 months of age, each we igh ting 200-230 g, was used in all ex pe ri ments. Stan dard rat chow and wa ter we re gi ven ad li bi tum, and ani mals we re ho u sed in gro ups of 3-4 rats un der stan dard con di ti ons (22 ± 2°C and 55% ± 5% re la ti ve hu mi dity) with 12-hour light-dark cycles. The ani mals we re clas si fi ed ran domly in to three gro ups, inc lu ding seven animals in each gro up. The gro ups we re as fol lows: (1) di a be tic gro up, (2) me la to nin-tre a ted di a be tic group, and (3) con trol gro up.
In two gro ups, di a be tes was in du ced with one do se of 60 mg/kg of in tra pe ri to ne al (i.p.) STZ, dis solved in cit ra te buf fer (pH 4.5). The glu co se le vel was me a su red as a pa ra me ter of DM with a glu co me ter in a ta il ve in four days af ter the be gin ning of the expe ri ment (Com pa ni on 2, Me di sen se, Bir ming ham, UK). All ani mals that were gi ven STZ de ve lo ped hypergl yce mi a wit hin 24 ho urs. The rats with se rum glu co se le vels >250 mg/dL we re ac cep ted as di a be tic. The last gro up, sham-ope ra ted con trol ani mals (Gro up 3), was in jec ted with iso to nic sa li ne so lu tion. One of the STZ-in du ced gro ups was not furt her tre a ted. The ot her gro up was in jec ted with 10 mg/kg/day of me la to nin (Sig ma, St. Lo u is, USA) i.p. dis sol ved in a so lu ti on of 20% et ha nol in 0.8% sa line, fol lo wing STZ tre at ment, and it con ti nu ed un til rats we re kil led. All ani mals we re eut ha ni zed at the end of 30 th day. The rats we re sac ri fi ced by car di ac punc tu re un der et her anest he si a and trans car di ally per fu sed with he pa ri ni zed sa li ne fol lo wed by 10% for ma lin in phosp ha te buf fer. The eyes we re enucle a ted, and dis sec ted qu ickly un der the ste re o-micros co pe in the light. The eye ball was cut pos te ri orly to the lim bus, and then an te ri or seg ment was discar ded. The vit re o us was re mo ved, and the re ti na was ca re fully dis sec ted from the scle ra/cho ro id/pigment epit he li um and was used for the MDA flu o romet ric as say. The wet we ight of the iso la ted re ti na was me a su red as so on as pos sib le. Then re ti nal tis sue was kept fro zen at -80 °C un til the sub se qu ent bioc he mi cal analy ses we re per for med. Re ti na samp les from each rat in all ex pe ri men tal gro ups we re used for me a su re ment of to tal MDA con cen tra ti ons. Le vels of MDA for each re ti na we re me a su red spectrof lu o ri met ri cally, using the mo di fi ed thi o bar bi tuTurkiye Klinikleri J Med Sci 2011;31 (2) ric acid-re ac ti ve subs tan ce (TBARS) met hod. 10 TBAR is re cog ni zed as the end pro duct of pol yunsa tu ra ted fatty acid pe ro xi da ti on and it is al so formed du ring in jury of DNA, pro te ins and car bohy dra tes.
Re ti nal samp les we re ho mo ge ni zed in a vo lume of one-tenth re ti na we ight of ice-cold 6% perc hlo ric acid at 4 °C with a glass ho mo ge ni zer. Ap pro xi ma tely 200 ml of su per na tant was col lected af ter cen tri fu ga ti on at 4000 g for 10 mi nu tes at 4 °C. Stan dards we re pre pa red from dif fe rent di luti ons of 1,1,3,3,-tet ra et hoxy pro pa ne. Tet ra et hoxypro pa ne was hydroly zed in acid (0.125 M in 0.125 M HCI, to tal vo lu me 80 ml) for 24 ho urs at ro om tem pe ra tu re; pH was ad jus ted to 6.9 with 2 M Na -OH. The vo lu me was fil led up to 100 ml with distil led wa ter.
The re ac ti on mix tu re con ta i ned 100 µl of each samp le (stan dards, re ti na samp les and blank), 200 ml of 8.1% so di um do decyl sul fa te (SDS, Sig ma Chem., Co., USA), 200 µl of ace tic acid so lu ti on (pH: 3.5), and 200 µl of 0.8% thi o bar bi tu ric acid (dis sol ved in 10% ace tic acid, pH 3.5) and wa ter was ad ded to a fi nal vo lu me of 1 ml. The mix tu res we re then pla ced in to a he a ting block at 95 °C for 45 mi nu tes, and then co o led to ro om tem pe ra tu re with tap wa ter. Samp les we re then cen tri fu ged at 4000 g for 10 mi nu tes. The su per na tant was me asu red by spec trof lu o ri metry, with ex ci ta ti on at 520 nm and emis si on at 555 nm. Cal cu la ti ons we re perfor med using a li ne ar reg res si on from tet ra et hoxypro pa ne for the MDA stan dard cur ve. Re a dings we re ex pres sed in nmol/100 mg tis su e wet we ight using the reg res si on equ a ti on.
Dif fe ren ces among the thre e gro ups for MDA le vels we re eva lu a ted using one-way ANO VA analy sis, whe re app li cab le. The Tu key's test was used as post hoc test af ter one-way ANO VA. The le vel of sig ni fi can ce was set at <0.05. All sta tis ti cal analy ses of the study we re per for med by using SPSS for Win dows (SPSS Inc., Chi ca go, IL, USA) soft wa re.
RE SULTS
The wet we ight ran ge of the iso la ted re ti nas was bet we en 15-23 mg. Di a be tic ani mals ex hi bi ted many symptoms com monly as so ci a ted with di a betes (e.g. pol yu ri a, poly dip si a and di arr he a). Fi nal me an plas ma glu co se le vels in the di a be tic gro up, me la to nin-tre a ted di a be tic gro up, and con trol groups we re 378.25 ± 59.01 mg/dl, 363.08 ± 69.13 mg/dl, and 112.30 ± 21.2 mg/dl, res pec ti vely. The STZ-in du ced di a be tic ani mals ex hi bited hyperglyce mi a. Me la to nin tre at ment did not sig ni fi cantly chan ge blo od glu co se le vels of di a be tic ani mals and did not af fect blo od glu co se le vels of the con trol gro up.
The me an MDA le vels in tis su e wet-we ight of re ti nas we re 55.68 ± 6.04 per 100 mg in di a be tic rats in du ced with STZ, 36.13 ± 7.48 per 100 mg in di a betic rats tre a ted with me la to nin, and 23.04 ± 4.03 per 100 mg tis su e in con trol gro up. The me an va lu es of the MDA for thre e gro ups are shown in Tab le 1. Oneway ANO VA sho wed sta tis ti cally sig ni fi cant dif feren ces among the thre e gro ups (p= 0.0001; F= 84.82; df= 2; one-way ANO VA). The MDA le vels, as a marker of li pid pe ro xi da ti on, we re hig her in the re ti nal ho mo ge na tes of diabetic ani mals than eit her con trol animals or di a be tic ani mals tre a ted with me la to nin (p< 0.001, p< 0.01, res pec ti vely). The re was al so diffe ren ce bet we en the di a be tic and me la to nin-tre a ted di a be tic gro ups for re ti nal MDA le vels (p< 0.01). MDA le vels of di a be tic ani mals tre a ted with me la tonin we re not dif fe rent from con trol gro up (p> 0.05).
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DIS CUS SI ON
DM is the most com mon en doc ri ne di se a se that leads to me ta bo lic di sor ders in vol ving re gu la ti on of car bohy dra te me ta bo lism. The se ab nor ma li ti es pro du ce pat ho lo gi es inc lu ding vas cu lo pat hi es, neu ro pat hi es, oph thal mo pat hi es and nep hro pat hi es, among many ot her me di cal di sor ders. 1 An ex ces sive and/or sus ta i ned in cre a se in re ac ti ve oxy gen speci es (ROS) pro duc ti on has be en imp li ca ted in the pat ho ge ne sis of can cer, di a be tes mel li tus, at he roscle ro sis, ne u ro de ge ne ra ti ve di se a ses, rhe u ma to id art hri tis, isc he mi a/re per fu si on in jury, and ot her dise a ses. 11 Oxi da ti ve stress plays a ro le in the de velop ment of di a be tic comp li ca ti ons. 12 Ele va ted glu co se le vels are as so ci a ted with in cre a sed pro ducti on of ROS by se ve ral dif fe rent mec ha nisms. 11 In cul tu red bo vi ne aor tic en dot he li al cells, hyperglyce mi a was shown to ca u se in cre a sed ROS pro ducti on at the mi toc hon dri al comp lex. In ad di ti on, su pe ro xi de is ge ne ra ted by the pro cess of glu co se au to-oxi da ti on that is as so ci a ted with the for ma tion of glyca ted pro te ins in the plas ma of di a be tic pati ents. The in te rac ti on of ad van ced glyca ti on end-pro ducts with cor res pon ding cell sur fa ce recep tors sti mu la tes ROS pro duc ti on and dec re a ses in tra cel lu lar glu tat hi o ne le vels. In di a be tes mel litus, li pid pe ro xi da ti on can be in du ced by pro te in glyca ti on and glu co se au to-oxi da ti on that le ads to the for ma ti on of fre e ra di cals. 13 The se fre e ra di cals all might play a ro le in DNA da ma ge, glyca ti on and pro te in mo di fi ca ti on re ac ti ons, and in li pid oxi dati ve mo di fi ca ti on in di a be tes. The in cre a se in ROS pro duc ti on con tri bu tes to the de ve lop ment of di abe tic comp li ca ti ons such as at he rosc le ro sis and ot her vas cu lar comp li ca ti ons. In ad di ti on, hyperglyce mi a en han ces cell-me di a ted low-den sity li popro te in pe ro xi da ti on in en dot he li al cells. Tre at ment with an ti o xi dants ame li o ra tes di a be tic comp li ca tions inc lu ding the dysfunc ti on of en dot he li al cells or in cre a sed pla te let ag gre ga ti on.
11
The da ma ge ca u sed by the se ra di cals on the cells might be qu an ti ta ti vely de ter mi ned by me asu re ment of le vels of MDA, a pro duct of li pid pe ro xi da ti on. MDA is a deg ra ded pro duct of li pid pe ro xi da ti on that can pro du ce cyto to xi city by re acting with the ami no ter mi nals of nuc le ic acid. 13 Chan ges of MDA le vels are an in di ca tor of degree of li pid pe ro xi da ti on and the re fo re ref lect the seve rity of tis su e da ma ge.
14 In our study, se ve re re tinal da ma ge was me a su red by in cre a sed le vels of MDA.
Me la to nin is an im por tant com po nent of the an ti o xi dant pro fi le of many tis su es. It is a ma jor scaven ger of both oxy gen-and nit ro gen-ba sed re ac tive mo le cu les. 15 It has sca ven ging ac ti ons at both physi o lo gic and phar ma co lo gic con cen tra ti ons. Not only me la to nin but al so se ve ral of its me ta bo li tes can de to xify fre e ra di cals and the ir de ri va ti ves. 15 Mo re o ver, me la to nin in du ces the ac ti vity of γ-glutamylc yste i ne synthe ta se, sti mu la ting the pro ducti on of anot her in tra cel lu lar an ti o xi dant, glu tat hi o ne. Me la to nin al so sup ports se ve ral in tracel lu lar enz yma tic an ti o xi dant enz ymes, inc lu ding su pe ro xi de dis mu ta ses and glu tat hi o ne pe ro xi dase. 16 It pos ses ses ge no mic ac ti ons and re gu la tes the ex pres si on of se ve ral ge nes, inc lu ding tho se for supe ro xi de dis mu ta ses and glu tat hi o ne pe ro xi da se. Me la to nin inf lu en ces both an ti o xi dant enz yme acti vity and cel lu lar mRNA le vels for the se enz ymes un der physi o lo gi cal con di ti ons and du ring ele vated oxi da ti ve stress. 16 It en han ces abi lity of cells to re sist oxi da ti ve da ma ge by in hi bi ting the pro-oxidant nit ric oxi de syntha se. 17 An ti o xi dant ca pa city of me la to nin on plas ma has be en well es tab lis hed in the li te ra tu re. 9 Hus se in et al. 18 sho wed that a sing le and high do se of me la to nin pro vi ded pro tec tion in X-ray-in du ced skin da ma ge in rats. An war and Mo us ta fa 19 ha ve do cu men ted the pre ven ti ve and tre at ment ro le of syste mically app li ed me la tonin aga inst ul tra vi o let-in du ced oxi da ti ve stress in the rat lens. Var dı et al. 20 in ves ti ga ted the im proving ef fects of me la to nin on the his to lo gi cal al tera ti ons of the li ver in the STZ-in du ced di a be tic rat mo del. In his to lo gi cal in ves ti ga ti ons, hydro pic and nuc le ar chan ges we re ob ser ved in the he pa tocy tes in the di a be tic gro up. In ad di ti on, both glyco gen gra nu les in the he pa tocy te cytop lasm and mast cell gra nu les had dec re a sed com pa red to the con trol and DM gro ups, and this im pro ve ment has be en ascri bed to me la to nin. Var dı et al. sug gest that me lato nin may be used to pre vent di a be tic li ver da ma ge.
